The National Cancer Institute (NCI) awarded a Project Grant totaling $130,001 to Northwestern University to conduct research on physical activity promotion interventions for breast cancer survivors with cancer-related fatigue. The award, funded under the NCI's Cancer Research Manpower (CFDA 93.398) program, aims to explore the effects of different physical activity intervention components in this population and understand multi-level preferences to inform future intervention development. The...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) will fund a $414,446 study to examine the efficacy of a group-based videoconference intervention to increase moderate-to-vigorous physical activity (MVPA) among cancer survivors. The 12-week intervention will include twice-weekly instructor-led group aerobic and resistance exercise sessions, as well as PA behavior change discussions, all delivered via...
The National Cancer Institute (NCI) awarded a $794,530 Project Grant (CFDA 93.394 - Cancer Detection and Diagnosis Research) to the Sloan-Kettering Institute for Cancer Research to conduct a phase IIb randomized controlled trial evaluating the efficacy of time-restricted eating to reduce weight and improve markers of cardiometabolic risk in 300 radiation-exposed survivors of childhood cancer with overweight/obesity. The study will leverage novel mHealth technology to deliver a remote,...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $140,828 to develop and pilot test community-driven implementation strategies to increase the uptake of built environment approaches that promote physical activity. The project aims to systematically select and tailor implementation strategies in collaboration with Extension professionals, then pilot test the tailored strategies through an...
This federal Project Grant award, funded by the National Cancer Institute (CFDA 93.394 Cancer Detection and Diagnosis Research), provides $331,781 to Northwestern University to refine and enhance intervention tools for reducing unprotected sun exposure among melanoma survivors. The project, titled "SESAME: SUN EXPOSURE AND ACTIVITIES AFTER SKIN CANCER: OPTIMIZATION OF MHEALTH INTERVENTIONS," aims to develop an integrated mobile health (mHealth) app that combines ultraviolet radiation...
The National Cancer Institute (NCI) awarded a $696,140 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to The Trustees of Columbia University in the City of New York, Health Sciences Division, to develop and test the ICAN DEPCARE strategy. This hybrid III effectiveness-implementation trial aims to efficiently and sustainably deliver complex treatment algorithms/guidelines, facilitate communication/triage/referral processes for oncology teams, and increase the proportion of...
The National Cancer Institute (NCI) has awarded a $621,732 project grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The Medical University of South Carolina (MUSC). The grant will fund a 5-year hybrid effectiveness-implementation trial to evaluate a proactive identification and digital mental health intervention approach to address unmet psychosocial needs of individuals living with likely incurable cancer. The key products and services to be delivered through this...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will support the development and evaluation of a mobile-optimized personalized cancer support tool for young adult cancer survivors. The $290,052 award to the Regents of the University of Michigan will fund the refinement and pilot testing of the "PERCS-YA" intervention, which aims to reduce worry and distress among young adults diagnosed with common...
This $650,412 federal Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) supports an efficacy trial of the "Healthy Juntos" family-based digital lifestyle intervention for Hispanic adolescents and their parents. The project aims to address obesity, physical inactivity, and poor diet - major modifiable risk factors for cancer, which is a leading cause of death among U.S. Hispanics. The 5-year project, awarded to the...
The National Cancer Institute (NCI) awarded a $707,367 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Kaiser Foundation Hospitals to evaluate a novel mobile health (mHealth) smoking cessation intervention for people who are ambivalent about quitting smoking. The 5-year project, titled "Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking: A Randomized Controlled Trial," will develop and test the...